Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy

The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (<i>Id1</i>) and inhibitor of differentiation 3 <i>(Id3)</i> (referred to as <i>Id</i>) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Archana P. Thankamony, Reshma Murali, Nitheesh Karthikeyan, Binitha Anu Varghese, Wee S. Teo, Andrea McFarland, Daniel L. Roden, Holly Holliday, Christina Valbirk Konrad, Aurelie Cazet, Eoin Dodson, Jessica Yang, Laura A. Baker, Jason T. George, Herbert Levine, Mohit Kumar Jolly, Alexander Swarbrick, Radhika Nair
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2020-09-01
Seri Bilgileri:Biomolecules
Konular:
cancer stem cells
chemoresistance
self-renewal
combination therapy
<i>Id1</i>
<i>Kif11</i>
Online Erişim:https://www.mdpi.com/2218-273X/10/9/1295
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller